Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic mucocutaneous candidiasis

C H Kirkpatrick1

  • 1Department of Medicine, University of Colorado Health Sciences Center, Denver.

Journal of the American Academy of Dermatology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

Clinical and experimental immunology·2014
Same author

Chronic mucocutaneous candidiasis.

The Pediatric infectious disease journal·2001
Same author

Transfer factors: identification of conserved sequences in transfer factor molecules.

Molecular medicine (Cambridge, Mass.)·2000
Same author

Eleventh International Congress on Transfer Factors: March 1-4, 1999, Monterrey, Nuevo Leon, Mexico.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2000
Same author

Recognition of the immunocompromised patient.

Chest surgery clinics of North America·1999
Same author

A man with multiple infections with unusual organisms.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1999
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Guo et al., "Response to Huang et al.'s 'Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: an analysis of national multicenter data from the CRDC.'".

Journal of the American Academy of Dermatology·2026
Same journal

Genomic Predictors of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Insights from an MD Anderson Cohort.

Journal of the American Academy of Dermatology·2026
See all related articles

Chronic mucocutaneous candidiasis involves recurrent Candida albicans infections. Treatment requires antifungal drugs and correcting underlying immunologic issues for these complex cases.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Dermatology

Background:

  • Chronic mucocutaneous candidiasis (CMC) is characterized by persistent Candida albicans infections affecting skin, nails, and mucous membranes.
  • CMC presents with diverse patient subgroups, identified by associated conditions like autoimmune diseases, endocrinopathies, thymoma, and interstitial keratitis.
  • Coexisting disorders in CMC patients can include other infections, endocrinopathies, dental enamel dysplasia, vitiligo, and alopecia totalis.

Purpose of the Study:

  • To elucidate the complexity of chronic mucocutaneous candidiasis.
  • To highlight the varied clinical presentations and associated disorders in CMC patients.
  • To emphasize the need for comprehensive treatment strategies.

Main Methods:

  • Clinical case review and analysis of patient subgroups.

Related Experiment Videos

  • Identification of associated autoimmune diseases, endocrinopathies, and other comorbidities.
  • Assessment of Candida infection distribution and severity.

    • Main Results:

    • CMC is a complex disorder with distinct patient subgroups.
    • Associated conditions significantly influence disease presentation and management.
    • The severity and distribution of Candida infections vary among patients.

    Conclusions:

    • Successful CMC management necessitates a dual approach: antifungal therapy and correction of predisposing immunologic abnormalities.
    • Understanding associated disorders is crucial for effective treatment planning.
    • Integrated care addressing both infection and immune dysfunction is key for CMC patients.